~~<i id='8F7D334AEB'><strike id='8F7D334AEB'><tt id='8F7D334AEB'><pre id='8F7D334AEB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

WSS

Notifications
- Wikipedia
Jerome Adams on the need for new antivirals for Covid
log on

hotspot

fashion

author：explore 2025-09-27 12:34:16 - browse：499

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： The woman behind the Dana Farber

Wikipedia

knowledge

Wikipedia

hotspot

leisure time

AdobeSANDIEGO—OneofthetoughestsubtypesofacuteleukemiainvolvesageneticalterationintheKMT2Agene.Manyca

WSS

After sickle

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Elizabeth Holmes banned from government health programs

Medicare Advantage today, explained in one chart

eGenesis tests gene

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

hotspot

fashion

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

In diabetes hearing, Sanders takes on a new foe: food makers

Trump demands the U.S. pay no more for drugs than other countries … again

CMS should re

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Teach medical students about patients with intellectual disabilities

Medical leaders decry Supreme Court decision on affirmative action

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

How one medical school became remarkably diverse

Congenital heart disease patients face new threat of heart failure

knowledge

In diabetes hearing, Sanders takes on a new foe: food makers

AI generated plenty of interest at JPM but not a lot of trust

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Supreme Court wrestles with OxyContin maker's bankruptcy deal

The tragedy of Johnson & Johnson’s Covid vaccine

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Wikipedia

hotspot

hotspot

leisure time